Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA.
Dig Liver Dis. 2012 Jun;44(6):497-503. doi: 10.1016/j.dld.2011.12.014. Epub 2012 Feb 18.
An estimated 3.2 million persons are chronically infected with the hepatitis C virus (HCV) in the U.S. Effective treatment is available, but approximately 50% of patients are not aware that they are infected. Optimal testing strategies have not been described.
The Hepatitis C Assessment and Testing Project (HepCAT) was a serial cross-sectional evaluation of two community-based interventions designed to increase HCV testing in urban primary care clinics in comparison with a baseline period. The first intervention (risk-based screener) prompted physicians to order HCV tests based on the presence of HCV-related risks. The second intervention (birth cohort) prompted physicians to order HCV tests on all patients born within a high-prevalence birth cohort (1945-1964). The study was conducted at three primary care clinics in the Bronx, New York.
Both interventions were associated with an increased proportion of patients tested for HCV from 6.0% at baseline to 13.1% during the risk-based screener period (P<0.001) and 9.9% during the birth cohort period (P<0.001).
Two simple clinical reminder interventions were associated with significantly increased HCV testing rates. Our findings suggest that HCV screening programs, using either a risk-based or birth cohort strategy, should be adopted in primary care settings so that HCV-infected patients may benefit from antiviral treatment.
据估计,美国有 320 万人慢性感染丙型肝炎病毒(HCV)。目前已有有效的治疗方法,但约有 50%的患者不知道自己已被感染。尚未描述最佳的检测策略。
丙型肝炎评估和检测项目(HepCAT)是对两项基于社区的干预措施的连续横断面评估,旨在与基线期相比,增加城市初级保健诊所的 HCV 检测。第一项干预措施(基于风险的筛查器)促使医生根据存在 HCV 相关风险来安排 HCV 检测。第二项干预措施(出生队列)促使医生对所有出生于高流行出生队列(1945-1964 年)的患者进行 HCV 检测。该研究在纽约布朗克斯的三个初级保健诊所进行。
两种干预措施均与 HCV 检测比例增加相关,从基线时的 6.0%增加到风险筛查器期间的 13.1%(P<0.001)和出生队列期间的 9.9%(P<0.001)。
两种简单的临床提醒干预措施与 HCV 检测率显著增加相关。我们的发现表明,应在初级保健环境中采用基于风险或出生队列的 HCV 筛查计划,以便 HCV 感染患者能够受益于抗病毒治疗。